Register

Institutional Sign In

Go
Home » Companies » Retail & Wholesale in Czechia » Lekarna.cz

Lekarna.cz

Lekarna.cz's net profit rose 45.5% yoy to CZK 47.4 mil in 2021

By Helgi Library - May 21, 2023

Lekarna.cz made a net profit of CZK 47.4 mil with revenues of CZK 1,610 mil in 2021, up by 45.5% and up by 26.6%, r...

Lekarna.cz's employees rose 26.2% yoy to 130 in 2021

By Helgi Library - May 21, 2023

Lekarna.cz employed 130 employees in 2021, up 26.2% compared to the previous year. Historically, between 2010 and 2021,...

Lekarna.cz's Capital Expenditures fell 34.6% yoy to CZK 25.9 mil in 2021

By Helgi Library - May 21, 2023

Lekarna.cz invested a total of CZK 25.9 mil in 2021, up 34.6% compared to the previous year. Historically, between 2007 ...

Profit Statement 2019 2020 2021
Sales CZK mil 720 1,272 1,610
Gross Profit CZK mil 71.2 118 147
EBITDA CZK mil 16.9 46.8 65.8
EBIT CZK mil 10.9 40.4 60.4
Financing Cost CZK mil 1.21 0.365 0.299
Pre-Tax Profit CZK mil 8.23 40.7 59.4
Net Profit CZK mil 7.44 32.6 47.4
Balance Sheet 2019 2020 2021
Total Assets CZK mil 160 263 333
Non-Current Assets CZK mil 17.9 30.8 51.3
Current Assets CZK mil 139 226 272
Working Capital CZK mil 24.3 35.4 19.1
Shareholders' Equity CZK mil 31.1 63.1 105
Liabilities CZK mil 129 199 228
Total Debt CZK mil 32.9 32.8 32.5
Net Debt CZK mil 1.11 -24.0 -50.5
Ratios 2019 2020 2021
ROE % 27.3 69.2 56.3
ROCE % 14.4 60.1 69.5
Gross Margin % 9.88 9.31 9.14
EBITDA Margin % 2.35 3.68 4.09
EBIT Margin % 1.51 3.18 3.75
Net Margin % 1.03 2.56 2.95
Net Debt/EBITDA 0.066 -0.513 -0.767
Net Debt/Equity % 3.58 -38.1 -47.9
Cost of Financing % 2.76 1.11 0.916
Cash Flow 2019 2020 2021
Total Cash From Operations CZK mil 26.6 44.4 52.3
Total Cash From Investing CZK mil 0.401 -19.2 -25.9
Total Cash From Financing CZK mil -22.2 -0.089 -0.341
Net Change In Cash CZK mil 4.84 25.1 26.1
Cash Conversion Cycle days 9.35 7.23 1.55
Cash Earnings CZK mil 13.5 39.0 52.8
Free Cash Flow CZK mil 27.0 25.1 26.5

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
income statement                                
Sales CZK mil                   474 522 510 519 720    
Gross Profit CZK mil                   57.6 56.8 51.5 48.3 71.2    
EBIT CZK mil                   14.6 7.11 4.03 -5.56 10.9    
Net Profit CZK mil                   10.5 3.24 1.83 -8.17 7.44    
                                   
ROE % ...                 14.3 2.59 2.33 -29.5 27.3    
EBIT Margin %                   3.09 1.36 0.789 -1.07 1.51    
Net Margin %                   2.21 0.620 0.359 -1.57 1.03    
Employees ... ... ... ...           86.0 83.6 90.0 92.0 87.0    
balance sheet                                
Total Assets CZK mil                   125 125 138 140 160    
Non-Current Assets CZK mil                   8.64 11.1 12.2 23.3 17.9    
Current Assets CZK mil                   116 109 120 113 139    
                                   
Shareholders' Equity CZK mil                   125 125 31.8 23.5 31.1    
Liabilities CZK mil                   0 0 106 116 129    
Non-Current Liabilities CZK mil                   0 0 0 7.68 5.43    
Current Liabilities CZK mil                   86.4 79.1 91.0 102 115    
                                   
Net Debt/EBITDA                   0.115 0.754 4.10 -17.7 0.066    
Net Debt/Equity %                   1.42 5.10 78.4 118 3.58    
Cost of Financing % ... ... ... ... ... ...       2.72 1.54 1.28 2.28 2.76    
cash flow                                
Total Cash From Operations CZK mil ...                 3.34 -0.562 -13.0 4.11 26.6    
Total Cash From Investing CZK mil ...                 -2.01 -3.75 0.109 -3.86 0.401    
Total Cash From Financing CZK mil ...                 21.1 0.201 11.7 2.60 -22.2    
Net Change In Cash CZK mil ...                 22.4 -4.11 -1.11 2.85 4.84    
income statement Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
income statement                                
Sales CZK mil                   474 522 510 519 720    
Cost of Goods & Services CZK mil                   416 465 459 470 649    
Gross Profit CZK mil                   57.6 56.8 51.5 48.3 71.2    
Staff Cost CZK mil                   45.3 44.6 52.2 51.4 50.9    
EBITDA CZK mil                   15.4 8.46 6.09 -1.57 16.9    
Depreciation CZK mil                   0.770 1.35 2.06 3.99 6.06    
EBIT CZK mil                   14.6 7.11 4.03 -5.56 10.9    
Net Financing Cost CZK mil                   1.43 2.29 -2.04 2.01 2.66    
Financing Cost CZK mil                   0.559 0.483 0.517 1.18 1.21    
Financing Income CZK mil                   0.207 0.080 0.267 0.168 0.176    
FX (Gain) Loss CZK mil                   1.08 1.89 -2.29 0.994 1.63    
Extraordinary Cost CZK mil                   0 0 4.07 0 0    
Pre-Tax Profit CZK mil                   13.2 4.82 1.99 -7.56 8.23    
Tax CZK mil                   2.73 1.59 0.159 0.608 0.791    
Minorities CZK mil                   0 0 0 0 0    
Net Profit CZK mil                   10.5 3.24 1.83 -8.17 7.44    
Net Profit Avail. to Common CZK mil                   10.5 3.24 1.83 -8.17 7.44    
growth rates                                
Total Revenue Growth % ...                 -13.7 10.1 -2.19 1.64 38.9    
Staff Cost Growth % ...                 -29.3 -1.57 17.1 -1.67 -0.820    
EBITDA Growth % ...                 -200 -45.1 -28.0 -126 -1,182    
EBIT Growth % ...                 -188 -51.4 -43.4 -238 -296    
Pre-Tax Profit Growth % ...                 -383 -63.5 -58.7 -480 -209    
Net Profit Growth % ...                 -306 -69.1 -43.4 -546 -191    
ratios                                
ROE % ...                 14.3 2.59 2.33 -29.5 27.3    
ROA % ...                 9.89 2.59 1.39 -5.89 4.97    
ROCE % ...                 36.3 9.89 4.25 -14.7 14.4    
Gross Margin %                   12.2 10.9 10.1 9.31 9.88    
EBITDA Margin %                   3.25 1.62 1.19 -0.302 2.35    
EBIT Margin %                   3.09 1.36 0.789 -1.07 1.51    
Net Margin %                   2.21 0.620 0.359 -1.57 1.03    
Cost of Financing % ... ... ... ... ... ...       2.72 1.54 1.28 2.28 2.76    
Net Debt/EBITDA                   0.115 0.754 4.10 -17.7 0.066    
balance sheet Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
balance sheet                                
Cash & Cash Equivalents CZK mil                   29.3 25.2 24.0 26.9 31.8    
Receivables CZK mil                   43.6 46.2 49.3 61.3 77.4    
Inventories CZK mil                   23.1 19.3 30.6 24.3 29.9    
Current Assets CZK mil                   116 109 120 113 139    
Property, Plant & Equipment CZK mil                   1.81 0.878 1.34 10.6 9.16    
LT Investments & Receivables CZK mil                   0 0 0 0 0    
Intangible Assets CZK mil                   4.48 7.48 9.03 10.4 6.32    
Goodwill CZK mil                   0 0 0 0 0    
Non-Current Assets CZK mil                   8.64 11.1 12.2 23.3 17.9    
Total Assets CZK mil                   125 125 138 140 160    
                                   
Trade Payables CZK mil                   46.0 40.5 42.0 47.6 83.0    
Short-Term Debt CZK mil                   31.1 31.6 49.0 46.9 27.5    
Other ST Liabilities CZK mil                   9.30 7.02 -0.014 7.70 4.99    
Current Liabilities CZK mil                   86.4 79.1 91.0 102 115    
Long-Term Debt CZK mil                   0 0 0 7.68 5.43    
Other LT Liabilities CZK mil                   0 0 0 0 0    
Non-Current Liabilities CZK mil                   0 0 0 7.68 5.43    
Liabilities CZK mil                   0 0 106 116 129    
Equity Before Minority Interest CZK mil                   125 125 31.8 23.5 31.1    
Minority Interest CZK mil                   0 0 0 0 0    
Equity CZK mil                   125 125 31.8 23.5 31.1    
growth rates                                
Total Asset Growth % ...                 44.2 0.097 9.99 1.36 14.6    
Shareholders' Equity Growth % ...                 487 0.097 -74.6 -26.1 32.2    
Net Debt Growth % ...                 -42.7 259 291 10.9 -96.0    
Total Debt Growth % ... ... ... ... ... ... ...     211 1.58 55.1 11.5 -39.8    
ratios                                
Total Debt CZK mil                   31.1 31.6 49.0 54.6 32.9    
Net Debt CZK mil                   1.78 6.38 25.0 27.7 1.11    
Working Capital CZK mil                   20.7 24.9 37.9 38.0 24.3    
Capital Employed CZK mil                   29.4 36.0 50.2 61.3 42.2    
Net Debt/Equity %                   1.42 5.10 78.4 118 3.58    
Current Ratio                   1.34 1.38 1.32 1.10 1.20    
Quick Ratio                   0.844 0.902 0.806 0.863 0.946    
cash flow Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
cash flow                                
Net Profit CZK mil                   10.5 3.24 1.83 -8.17 7.44    
Depreciation CZK mil                   0.770 1.35 2.06 3.99 6.06    
Non-Cash Items CZK mil ...                 -8.04 -0.962 -3.83 8.38 -0.663    
Change in Working Capital CZK mil ...                 0.141 -4.19 -13.0 -0.096 13.8    
Total Cash From Operations CZK mil ...                 3.34 -0.562 -13.0 4.11 26.6    
                                   
Capital Expenditures CZK mil ...                 -2.01 -3.85 -4.97 -1.69 0.220    
Other Investing Activities CZK mil ...                 0 0.099 5.08 -2.16 0.181    
Total Cash From Investing CZK mil ...                 -2.01 -3.75 0.109 -3.86 0.401    
                                   
Dividends Paid CZK mil ...                 0 0 -5.42 -0.001 0    
Issuance Of Shares CZK mil ...                 0 0 0 0 0    
Issuance Of Debt CZK mil ...                 21.1 0.490 17.2 2.60 -22.2    
Total Cash From Financing CZK mil ...                 21.1 0.201 11.7 2.60 -22.2    
                                   
Effect of FX Rates CZK mil ...                 0 ... 0 0 0    
Net Change In Cash CZK mil ...                 22.4 -4.11 -1.11 2.85 4.84    
ratios                                
Days Sales Outstanding days                   33.6 32.3 35.3 43.1 39.2    
Days Sales Of Inventory days                   20.3 15.1 24.4 18.9 16.8    
Days Payable Outstanding days                   40.3 31.8 33.4 36.9 46.7    
Cash Conversion Cycle days                   13.5 15.6 26.2 25.1 9.35    
Cash Earnings CZK mil                   11.2 4.59 3.90 -4.18 13.5    
Free Cash Flow CZK mil ...                 1.33 -4.31 -12.8 0.249 27.0    
Capital Expenditures (As % of Sales) % ...                 0.425 0.738 0.973 0.326 -0.031    
other ratios Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
                                 
Employees ... ... ... ...           86.0 83.6 90.0 92.0 87.0    
Cost Per Employee USD per month ... ... ... ...           1,840 1,763 2,061 2,126 2,164    
Cost Per Employee (Local Currency) CZK per month ... ... ... ...           43,913 44,471 48,355 46,515 48,785    
Material & Energy (As % of Sales) %                   72.2 73.3 74.4 74.8 78.0    
Services (As % of Sales) %                   15.7 15.8 15.6 15.9 12.2    
Staff Cost (As % of Sales) %                   9.56 8.55 10.2 9.90 7.07    
Effective Tax Rate %                   20.7 32.9 7.99 -8.04 9.61    
Total Revenue Growth (5-year average) % ... ... ... ... ...         10.4 7.72 3.56 0.771 5.59    
Total Revenue Growth (10-year average) % ... ... ... ... ... ... ... ... ... ... 18.7 13.2 9.41 11.2    

Get all company financials in excel:

Download Sample   $19.99

Lekarna.cz's ROCE rose 15.5% yoy to 69.5% in 2021

By Helgi Library - May 21, 2023

Lekarna.cz made a net profit of CZK 47.4 mil in 2021, up 45.5% compared to the previous year. Historically, between 2006 and 2021, the company's net profit reached a high of CZK 47.4 mil in 2021 and a low of CZK -15.4 mil in 2013. The result implies a ret...

Lekarna.cz's Net Margin rose 14.9% yoy to 2.95% in 2021

By Helgi Library - May 21, 2023

Lekarna.cz made a net profit of CZK 47.4 mil with revenues of CZK 1,610 mil in 2021, up by 45.5% and up by 26.6%, respectively, compared to the previous year. This translates into a net margin of 2.95%. Historically, between 2006 and 2021, the firmâ...

Lekarna.cz's Net Debt/EBITDA fell 49.5% yoy to -0.767 in 2021

By Helgi Library - May 21, 2023

Lekarna.cz's net debt stood at CZK -50.5 mil and accounted for -47.9% of equity at the end of 2021. The ratio is down 9.85 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 118% in 2018 and a low of ...

More News

Lekarna.cz is a Czech-based online pharmacy owned by Pears Health Cyber. The Company was set up by VladimĂ­r Finsterle in 1999 as an information portal about medications. In 2003, the Company turned into an e-shop and become the first online pharmacy in the Czech Republic.

Lekarna.cz Logo

Finance

Lekarna.cz has been growing its sales by 25.3% a year on average in the last 5 years. EBITDA has grown on average by 50.7% a year during that time to total of CZK 65.8 mil in 2021, or 4.09% of sales. That’s compared to 2.20% average margin seen in last five years.

The company netted CZK 47.4 mil in 2021 implying ROE of 56.3% and ROCE of 69.5%. Again, the average figures were 25.1% and 26.7%, respectively when looking at the previous 5 years.

Lekarna.cz’s net debt amounted to CZK -50.5 mil at the end of 2021, or -47.9% of equity. When compared to EBITDA, net debt was -0.767x, up when compared to average of -2.96x seen in the last 5 years.

More Companies in Czech Retail & Wholesale Sector

Helgi Library
Eliášova 38, Prague 6, 160 00, Czech Republic
Copyright © 2023 Helgi Library. All rights reserved.